{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:23:08Z","timestamp":1791894188787,"version":"4.3.4"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T00:00:00Z","timestamp":1522800000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13023-018-0783-9","type":"journal-article","created":{"date-parts":[[2018,4,19]],"date-time":"2018-04-19T15:12:29Z","timestamp":1524150749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Alitretinoin reduces erythema in inherited ichthyosis"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9417-9272","authenticated-orcid":false,"given":"Giuliana","family":"Onnis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Chiaverini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffroy","family":"Hickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dreyfus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Bourrat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette","family":"Mazereeuw-Hautier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,4]]},"reference":[{"key":"783_CR1","first-page":"109","volume":"12","author":"H Traupe","year":"2014","unstructured":"Traupe H, Fischer J, Oji V. Non-syndromic types of ichthyoses - an update. J Dtsch Dermatol Ges. 2014;12:109\u201321.","journal-title":"J Dtsch Dermatol Ges"},{"key":"783_CR2","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jaad.2009.11.020","volume":"63","author":"V Oji","year":"2010","unstructured":"Oji V, Tadini G, Akiyama M, Blanchet Bardon C, Bodemer C, Bourrat E, et al. Revised nomenclature and classification of inherited ichthyoses: results of the first ichthyosis consensus conference in Sor\u00e8ze 2009. J Am Acad Dermatol. 2010;63:607\u201341.","journal-title":"J Am Acad Dermatol"},{"key":"783_CR3","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1365-2133.2011.10701.x","volume":"166","author":"J Mazereeuw-Hautier","year":"2012","unstructured":"Mazereeuw-Hautier J, Dreyfus I, Barbarot S, Serrentino L, Bourdon-Lanoy E, Ezzedine K, et al. Factors influencing quality of life in patients with inherited ichthyosis: a qualitative study using focus groups. Br J Dermatol. 2012;166:646\u20138.","journal-title":"Br J Dermatol"},{"key":"783_CR4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.2340\/00015555-1710","volume":"94","author":"I Dreyfus","year":"2014","unstructured":"Dreyfus I, Bourrat E, Maruani A, Bessis D, Chiav\u00e9rini C, Vabres P, et al. Factors associated with impaired quality of life in adult patients suffering from ichthyosis. Acta Derm Venereol. 2014;94:344\u20136.","journal-title":"Acta Derm Venereol"},{"key":"783_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/j.1365-2133.2010.09755.x","volume":"162","author":"AD Ormerod","year":"2010","unstructured":"Ormerod AD, Campalani E, Goodfield MJ. BAD clinical standards unit. British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology. Br J Dermatol. 2010;162:952\u201363.","journal-title":"Br J Dermatol"},{"key":"783_CR6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2340\/0001555565359362","volume":"65","author":"A Vahlquist","year":"1985","unstructured":"Vahlquist A, L\u00f6\u00f6f L, Nordlinder H, Rollman O, Vahlquist C. Differential hepatotoxicity of two oral retinoids (etretinate and isotretinoin) in a patient with palmoplantar psoriasis. Acta Derm Venereol. 1985;65:359\u201362.","journal-title":"Acta Derm Venereol"},{"key":"783_CR7","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1007\/s40265-016-0621-0","volume":"76","author":"HA Blair","year":"2016","unstructured":"Blair HA, Scott LJ. Alitretinoin: a review in severe chronic hand eczema. Drugs. 2016;76:1271\u20139.","journal-title":"Drugs"},{"key":"783_CR8","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1111\/j.1365-2133.2008.08487.x","volume":"158","author":"T Ruzicka","year":"2008","unstructured":"Ruzicka T, Lynde CW, Jemec GB, Diepgen T, Berth-Jones J, Coenraads PJ, et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol. 2008;158:808\u201317.","journal-title":"Br J Dermatol"},{"key":"783_CR9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.2340\/00015555-1499","volume":"93","author":"SC Prasad","year":"2013","unstructured":"Prasad SC, Bygum A. Successful treatment with alitretinoin of dissecting cellulitis of the scalp in keratitis-ichthyosis-deafness syndrome. Acta Derm Venereol. 2013;93:473\u20134.","journal-title":"Acta Derm Venereol"},{"key":"783_CR10","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/archdermatol.2011.216","volume":"147","author":"S Werchau","year":"2011","unstructured":"Werchau S, Toberer F, Enk A, Hembold P. Keratitis-ichthyosis-deafness syndrome: response to alitretinoin and review of literature. Arch Dermatol. 2011;147:993\u20135.","journal-title":"Arch Dermatol"},{"key":"783_CR11","doi-asserted-by":"publisher","first-page":"256","DOI":"10.2340\/00015555-1302","volume":"92","author":"A G\u00e5nemo","year":"2012","unstructured":"G\u00e5nemo A, Sommerlund M, Vahlquist A. Oral alitretinoin in congenital ichthyosis: a pilot study shows variable effects and a risk of central hypothyroidism. Acta Derm Venereol. 2012;92:256\u20137.","journal-title":"Acta Derm Venereol"},{"key":"783_CR12","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2340\/00015555-1447","volume":"93","author":"A Bygum","year":"2013","unstructured":"Bygum A, Virtanen M, Brandrup F, G\u00e5nemo A, Sommerlund M, Strauss G, et al. Generalized and naevoid epidermolytic ichthyosis in Denmark: clinical and mutational findings. Acta Derm Venereol. 2013;93:309\u201313.","journal-title":"Acta Derm Venereol"},{"key":"783_CR13","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1080\/000155501750376221","volume":"81","author":"M Virtanen","year":"2001","unstructured":"Virtanen M, Gedde-Dahl T Jr, M\u00f6rk NJ, Leigh I, Bowden PE, Vahlquist A. Phenotypic\/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression. Acta Derm Venereol. 2001;81:163\u201370.","journal-title":"Acta Derm Venereol"},{"key":"783_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3109\/09546634.2015.1034080","volume":"27","author":"M Morris","year":"2016","unstructured":"Morris M, Schifano L, Fong R, Graff O. Safety of alitretinoin for severe refractory chronic hand eczema: clinical studies and postmarketing surveillance. J Dermatolog Treat. 2016;27:54\u20138.","journal-title":"J Dermatolog Treat"},{"key":"783_CR15","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2165\/11319020-000000000-00000","volume":"33","author":"E Chroni","year":"2010","unstructured":"Chroni E, Monastirli A, Tsambaos D. Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians. Drug Saf. 2010;33:25\u201334.","journal-title":"Drug Saf"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13023-018-0783-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-018-0783-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T06:06:45Z","timestamp":1693634805000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-018-0783-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,4]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["783"],"URL":"https:\/\/doi.org\/10.1186\/s13023-018-0783-9","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,4]]},"assertion":[{"value":"2 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the statutory and ethics authorities according to new French regulations regarding retrospective studies using data collected in medical files (Commision Nationale Informatique & Libert\u00e9s).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patients or their parents\/guardians gave the consent to publication of their anonymized clinical data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Pr J. Mazereeuw-Hautier is consultant for Arrow (acitretin)\u200b.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"46"}}